When should we thrombolyse patients with pulmonary embolism? A systematic review of the literature

Emergency Medicine Journal

Volumn 22, Issue 11, 2005, Pages 766-771

  Harris, T ^a   Meek, S ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b NORTH BRISTOL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RETEPLASE; STREPTOKINASE; TENECTEPLASE; UROKINASE;

BLEEDING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CLINICAL TRIAL; DRUG CHOICE; DRUG EFFICACY; DRUG FEVER; DRUG HYPERSENSITIVITY; EMBOLECTOMY; EMERGENCY MEDICINE; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; HEART ARREST; HEART RIGHT VENTRICLE FAILURE; HIGH RISK PATIENT; HUMAN; HYPOTENSION; LUNG EMBOLISM; META ANALYSIS; MORTALITY; NAUSEA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROPERITONEAL HEMORRHAGE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SHOCK; SYSTEMATIC REVIEW; VOMITING;

ANTICOAGULANTS; CRITICAL ILLNESS; DECISION MAKING; FIBRINOLYTIC AGENTS; HEART ARREST; HUMANS; PATIENT SELECTION; PULMONARY EMBOLISM; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; THROMBOLYTIC THERAPY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 27844469548     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2003.011965     Document Type: Review

References (70)

1. Oger E. Incidence of venous thromboembolism in a community-based study in western France. Thromb Haemost 2000;83:657-60.
2. Modam B, Sharon E, Jelin W. Factors contributing to the incorrect diagnosis of pulmonary embolism. Chest 1972;62:388-93.
3. Morpurgo M, Schmid C. Clinico-pathological correlations in pulmonary embolism. A prospective evaluation. Prog Respir Res 1980;13:8-15.
4. Pineda LA, Hathwar VS, Grant BJ. Clinical suspicion of fatal pulmonary embolism. Chest 2001;120:791-5.
5. Giuyini C, Ricco G, Marini C, et al. Updates in pulmonary embolism: epidemiology. Chest 1995;107(suppl):3-9.
6. Hull RD, Rushob GE, Carter CJ, et al. Pulmonary embolism I outpatients with pleuritc chest pain. Arch int Med 1988;148:838-44.
7. Pollak EW, sparks FC, Warber WF. Pulmonary embolism: an appraisal of 516 cases. Arch Surg 1972;107:66-8.
8. Barritt DW, Jordan SC. Anti coagulant drugs in the treatment of pulmonary embolism - a controlled trial. Lancet 1960;1:1309-12.
9. Goldhaber SZ, Visanai L, DeRosa M, for ICOPER. Acute pulmonary embolism: clinical outcomes of the International Cooperative Pulmonary Embolism Registry. Lancet 1999;353:1389-89.
10. Meyer G, Brenot F, Pacouret G, et al. Subcutaneous low molecular weight heparin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism. An open randomized pilot study. Haemost 1995;74:1432-35.
11. The Columbus Investigators. Low molecular weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997;337:657-62.
12. Simonneau G, Sors H, Charbonnier S for the THESEE study group. A comparison of low molecular weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997;337:663-9.
13. Dalen JE, Banas JS, Brook HK, et al. Resolution rate of acute pulmonary embolism in mice. N Engl J Med 1969;280:1194-99.
14. Arcasoy SM, Kreit JW. Thrombolytic therapy for pulmonary embolism - a comprehensive review of the current evidence. Chest 1999;115:1695-707.
15. Alpert JS, Smith R, Carlson J, et al. Mortality in patients treated for pulmonary embolism. JAMA 1976;236:1477-80.
16. Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right ventricular ventricular function and pulmonary perfusion. Lancet 1993;341:507-11.
17. Kasper W, Konstantinides S, Greibel A, et al. Management strategies and determinants of outcome in acute pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997;30:1165-71.
18. Kasper W, Konstantinides S, Greibel A, et al. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart 1997;77:346-9.
19. Konstantinides S, Giebel A, Oleschewski M, et al. Association between thrombolytic treatment and the prognosis of haemodynamically stable patients with major pulmonary embolism - results of a multicenter registry. Circulation 1997;96:882-8.
20. Urokinase Pulmonary Embolism Trial. Phase 1 results - a cooperative study. JAMA 1970;214:2163-72.
21. Tibbutt DA, Davies JA, Anderson JA, et al. Comparison by controlled clinical trial of streptokinase and heparin in the treatment of life threatening pulmonary embolism. BMJ 1974;1:343-7.
22. Ly B, Arnesen H, Erie H, et al. A controlled trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acto Med Scand 1978;203:465-70.
23. Marini C, Di Ricco G, Rosso G, et al. Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial. Respiration 1988;54:162-73.
24. PIOPED Investigators. Tissue plasminogen activator for the treatment of acute pulmonary embolism: a collaborative study by the PIOPED Investigators. Chest 1990;97:528-33.
25. Levine M, Hirsh J, Weitz J, et al. A randomized trial of a singe bolus regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest 1990:1473-9.
26. Dalla-Volta S, Palla A, Santolicandro A, et al. PAIMS 2: alteplase combined with heparin vs heparin in the treatment of pulmonary embolism: Plasminogen Activator Italian Multicenter study 2. J Am Coll Cardiol 1992;20:520-6.
27. Goldhaber SZ, Haire WD, Feldstein ML. Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right ventricular function and pulmonary perfusion. Lancet 1993;341:507-11.
28. Jerges-Sanchez C, Ramirez-Rivera A, Garcia M de L, et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism; a randomized controlled trial. J Thromb Thrombolysis 1995;2:227-9.
29. Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with sub massive pulmonary embolism. NEJM 2002;347:1143-50.
30. Thabut G, Thabut D, Myers RP, et al. Thrombolytic therapy for pulmonary embolism - A meta analysis. JACC 2002;40:1660-67.
31. Agnelli G, Becattini C, Kirschstein T. Thrombolysis vs heparin in the treatment of pulmonary embolism. A clinical outcome-based meta-analysis. Arch Intern Med 2002;162:2537-41.
32. Carson JL, Kelly MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992;326:1240-45.
33. Goldhaber SZ. Pulmonary embolism-broadening the paradigm for its administration. Circulation 1997;96:716-18.
34. Robertson C, Steen P, Bircher N, et al. The 1998 European Resuscitation Guidelines for adult advanced life support: as statement from the working group on ALS, and approved by the executive committee of the European resusitation council. Resuscitation 1998;1998:81-90.
35. Newman DH, Greenwald I, Callaway CW. Cardiac arrest and the role of thrombolytic agents. Ann Emerg Med 2000;35:472-80.
36. Bottiger BW, Bode C, Kern S. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet 2001;357:1583-5.
37. Bailen MR, Cuadra JA, De Hayes EA. Thrombolysis during CPR in fulminant pulmonary embolism: a review. Crit Care Med 2001;29:2211-19.
38. Hamel E, Pacouret G, Vincentelli D, et al. Thrombolysis or heparin in massive pulmonary embolism with right ventricular dilation. Chest 2001;120:120-5.
39. Konstinides S, Giebel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002;347:1143-50.
40. Wittlich W, Erbel A, Eichla S, et al. Detection of central pulmonary artery thromboemboli by transeosophegeal echocardiography in patients with severe PE. J Am Soc Echocardiography 1992;5:514-25.
41. John M, Furlong R, Schrank K. Diagnostic use of emergency department echo in massive PE. Ann Emerg Med 1992;21:260-3.
42. USET phase 2-urokinase-streptokinase trial: phase 2 results. JAMA 1974;229:1606-13.
43. Goldhaber S, Kessler C, Heit J, et al. Randomized controlled trial of rtPA versus urokinase in the treatment of acute pulmonary embolism. Lancet 1988;2:293-8.
44. Meyer G, Surs H, Charbonnier B, et al. Effects of intravenous urokinase versus alteplase on the total pulmonary resistance in acute massive pulmonary embolism: a European double blind trial. J Am Cardiol 1992;19:239-45.
45. Goldhaber S, Kessler C, Heit J, et al. Recombinant tissue-type plasminogen activator versus a novel dosing régime of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. J Am Coll Cardiol 1992;20:24-30.
46. Meneveau N, Schiele F, Vuillemenot A, et al. Streptokinase versus alteplase in massive PE: a randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction. Eur Heart J 1997;18:1141-48.
47. Meneveau N, Schiele F, Metz D, et al. Comparative efficiency of a 2 hour regimen of streptokinase versus alteplase in acute pulmonary embolism: immediate clinical and haemodynamic outcomes and one year follow up. J Am Coll Cardiol 1998;31:1057-63.
48. Goldhaber S, Agnelli G, Levine M, et al. Reduced dose bolus alteplase vs conventional alteplase infusion in massive pulmonary embolism: an international multicenter randomized trial. Chest 1994;106:718-24.
49. Tebe V, Graf A, Kambe W, et al. Haemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism. Am Heart J 1999;137:39-44.
50. Verstraete M, Miller G, Bounameaux H, et al. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation 1988;77:353-60.
51. Sors H, Pacouret G, Azarian R, et al. Haemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism: a randomized controlled multicenter trial. Chest 1994;106:712-17.
52. Gulba D, Bode C, Runge M, et al. Thrombolytics - an overview. Ann Haematol 1996;73(suppl):519-27.
53. Mikkola K, Patel s, Parker J, et al. Increasing age is a risk factor for haemorrhagic complications after pulmonary embolism. Am Heart J 1997;134:69-72.
54. Dalen J. thrombolytic therapy for pulmonary embolism, is it effective? Is it safe? When is it indicated? Arch Int Med 1997;157:2250-6.
55. Kanter D, Mikkola K, Patel S, et al. Thrombolytic therapy for pulmonary embolism - frequency of intracranial haemorrhage an associated risk factors. Chest 1997;111:1241-45.
56. Janata-Schwatczek K, Weiss K, Reizinger I, et al. Pulmonary embolism 2. Diagnosis and treatment. Sem Thromb Haemost 1996;22:33-52.
57. Greenfield L. Catheter pulmonary Embolectomy. Chest 1991;100:593-4.
58. Isoda. A case of acute massive pulmonary embolism treated by mechanical clot fragmentation using percutaneous angioplasty balloon. Jpn Circ J 1997;61:531-5.
59. Koning R, Cribier A, Gerber L, et al. A new treatment for severe pulmonary embolism:percutaneous rheolytic thrombectomy. Circulation 1997;96:2498-500.
60. De Gregorio M, Gimeno M, Mainar A, et al. Mechanical and enzymatic thrombolysis for acute massive pulmonary embolism. J Vasc Interv Radiol 2002;13:163-9.
61. Muller-Hulsbeck S, Brossmann J, Jahnke T, et al. Mechanical thrombectomy of major and massive pulmonary embolism with use of Amplatz thrombectomy device. Invest Radiol 2001;36:317-22.
62. Fava M, Loyola S, Heute I. Massive pulmonary embolism:treatment with hydrolysis thrombectomy catheter. J Vasc Interv Radiol 2000;11:1159-64.
63. Stock K, Jacob A, Schnabel K, et al. Massive pulmonary embolism: treatment with thrombus fragmentation and local fibrinolysis with rtPA. Cardiovasc Interv Radiol 1997;20:364-8.
64. Fava M, Loyola S, Flores P, et al. Mechanical fragmentation and pharmacological thrombolysis for massive pulmonary embolism. J Vasc Interv Radiol 1997;8:261-6.
65. Schmitz-Rode T, Janssens U, Schild H, et al. Fragmentation of massive pulmonary embolism using a pig rotation catheter. Chest 1998;14:1427-8.
66. Clark D, Abrams L. Pulmonary embolectomy. A 25-year experience. J Thorac Cardiovasc Surg 1986;92:442-5.
67. Doerge H, Schoendole T, Voss M, et al. Surgical therapy for fulminant pulmonary embolism: early and late results. Thorac Cardiovasc Surg 1999;47:9-13.
68. Gulba D, Schmid C, Borst H, et al. Medical compared to surgical treatment of massive pulmonary embolism. Lancet 1994;343:576-7.
69. Aklog L, Williams C, Byrne J, et al. Acute pulmonary embolectomy - a contempary approach. Circulation 2002;105:1416-22.
70. Miller, AC. British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax 2003;58:470-84.